Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |